Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity

Publication Date

October 1, 2007

Publication Information

Sadiq SA, and Poopatana CA. J Neurol. 2007; 254(10): 1464–1465.

Spasticity and pain are common features of multiple sclerosis (MS) [6]. Because pain may be relieved by anti-spasticity measures, treatment of spasticity should precede specific pain management. About 20 % of MS patients are either intolerant to oral medications or continue to have significant spasticity despite maximal oral dosage. These patients are optimally managed with continuous intrathecal baclofen infusion (ITB) administered via a surgically implanted programmable pump, a FDA-approved treatment modality [7, 8]. For patients with pain associated with spasticity, ITB therapy usually provides adequate relief of both symptoms.

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Look for the IFF Building on the North side of 57th Street across from the CBS building

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.